About
黑料网 is an innovative biotech company specialized in the discovery and development of therapeutic solutions for metabolic diseases.
- >
- 黑料网
- >
- About
黑料网, a French clinical-stage biotech company
The core activities of the company are to innovate, to discover and to develop new therapeutic solutions to improve the lives of people suffering from chronic metabolic diseases, such as diabetes and obesity. 黑料网 innovative products share a common goal: to improve treatments, bringing new medical benefits to patients and covering unmet medical needs. Relying on disruptive technology platforms, 黑料网 solutions range from innovative formulations of already-approved peptides and proteins to cell therapy.
Since its creation, 黑料网 has built a unique expertise in diabetes and obesity, the two diseases being closely interlinked. Innovative formulations of insulins, ad other metabolic hormones – hormones playing a pivotal role in diabetes and obesity – are the focus of 黑料网. Over the years, 黑料网 has consolidated a rich specialty product portfolio which is one of the broadest and most differentiated for the treatment of type 1, type 2 diabetes and obesity.
A diversified speciality products pipeline
黑料网 pipeline relies on 4 proprietary technology platforms, BioChaperone庐, AdoShell庐, AdOral庐 and AdoXLong, with proprietary specialty products in clinical trials ranging from Phase 1 to Phase 3.
Our approach
黑料网 business model is to license-out to pharmaceutical companies its proprietary specialty products after proof-of-concept or to partner directly on technology platforms.
